Olaparib Tablets News

20 Jul 202611:17 am

Finance20 Jul 2026 · 11:17 am11:17 am

Natco Pharma Shares Surge 5% After US FDA Tentative Nod for Olaparib Tablets

Natco Pharma shares surged 5% after receiving tentative approval from the U.S. FDA for its generic Olaparib tablets, a bioequivalent version of AstraZeneca's Ly

19 Jul 20265:19 pm

Business19 Jul 2026 · 5:19 pm5:19 pm

Create visual

Alembic Pharma and NATCO Receive Tentative USFDA Approval for Generic Olaparib Tablets

Alembic Pharmaceuticals and NATCO Pharma have received tentative USFDA approval for generic Olaparib tablets, a cancer drug with an estimated US market size of

Olaparib Tablets News

#Olaparib Tablets

Natco Pharma Shares Surge 5% After US FDA Tentative Nod for Olaparib Tablets

Alembic Pharma and NATCO Receive Tentative USFDA Approval for Generic Olaparib Tablets

Discover Faster

Stay Organized

Create Effortlessly

Drive Greater Impact

Newsroom FAQs